Skip to content

COVID-19 casts a shadow over progress on TB

a man who looks unwell, sneezing into a tissue

Major TB reduction impossible without expansion of ART coverage

A nurse in the TB-HIV room of a clinic in Kenya. © 2013 Alfredo L Fort, Courtesy of Photoshare

Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV

Kelly Dooley at CROI 2019. Photo by Liz Highleyman.

TB vaccine halves risk of disease in people with latent TB

One in five exposed to TB during HIV clinic visits, Malawi study finds

TB symptom screen less likely to detect active TB in people taking HIV treatment

New TB cases occur rapidly among close contacts of people with pulmonary TB

Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment

Isoniazid preventive therapy: do the risks outweigh the benefits in pregnant women with HIV?